• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

急性髓系白血病的治疗失败

Treatment failure in AML.

作者信息

Preisler H D

出版信息

Blood Cells. 1982;8(3):585-602.

PMID:6760935
Abstract

Emphasis on the reasons for successful therapy in the treatment of acute myelocytic leukemia (AML) has generally obscured the problem of treatment failures. This paper discusses failures in remission induction and relapse of leukemia. The contribution of patient-related factors as well as the heterogeneous characteristics of the leukemic cells are considered.

摘要

对急性髓细胞白血病（AML）治疗中成功治疗原因的强调通常掩盖了治疗失败的问题。本文讨论白血病缓解诱导失败和复发的情况。同时考虑了患者相关因素的作用以及白血病细胞的异质性特征。

相似文献

1
Treatment failure in AML.急性髓系白血病的治疗失败
Blood Cells. 1982;8(3):585-602.
2
Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.全血细胞增多症后急性髓系白血病、急性早幼粒细胞白血病及急变期经全反式维甲酸和粒细胞集落刺激因子治疗后的外周血及骨髓变化
Haematologica. 1996 May-Jun;81(3):261-4.
3
Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).急性髓系白血病（AML）诱导治疗阶段的骨髓形态学
Hematol Pathol. 1995;9(2):95-106.
4
Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.再生骨髓中髓系前体细胞增加；对急性髓系白血病微小残留病检测的意义。
Neoplasma. 2007;54(6):471-7.
5
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.复发/难治性急性髓系白血病患者接受克拉屈滨、阿糖胞苷（Ara-C）、粒细胞集落刺激因子（G-CSF）（CLAG方案）及同步递增剂量甲磺酸伊马替尼（格列卫）的I期研究。
Leuk Res. 2008 Dec;32(12):1830-6. doi: 10.1016/j.leukres.2008.04.026. Epub 2008 Jun 20.
6
[Modern strategies in therapy of acute myeloid leukemia (AML) in adulthood. I. Primary treatment of de novo AML].[成人急性髓系白血病（AML）治疗的现代策略。I. 初发AML的初始治疗]
Internist (Berl). 1996 Jun;37(6):661-8.
7
Advances in understanding the biology and genetics of acute myelocytic leukemia.急性髓细胞白血病生物学与遗传学研究进展
Clin Lab Sci. 2005 Winter;18(1):28-37.
8
[How to be an administration schedule of antileukemic agents in the treatment of acute leukemia from the standpoint of leukemic cell kinetics (author's transl)].
Nihon Ketsueki Gakkai Zasshi. 1974 Oct;37(5):707-30.
9
IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.IDA-FLAG方案治疗原发性难治性和复发性急性白血病：单中心经验
Am J Ther. 2006 Sep-Oct;13(5):389-93. doi: 10.1097/01.mjt.0000181690.21601.09.
10
Treatment strategies in acute myeloid leukemia.急性髓系白血病的治疗策略。
Chin Med J (Engl). 2011 May;124(9):1409-21.

引用本文的文献

1
Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia.
Cancer Chemother Pharmacol. 1984;12(2):125-30. doi: 10.1007/BF00254604.
2
Potential limitations of in vitro clonogenic drug sensitivity assays.体外克隆形成药物敏感性试验的潜在局限性。
Cancer Chemother Pharmacol. 1984;13(3):206-10. doi: 10.1007/BF00269030.
3
Development of drug resistance in a murine mammary tumour.小鼠乳腺肿瘤中耐药性的产生
Br J Cancer. 1985 Dec;52(6):823-32. doi: 10.1038/bjc.1985.265.
4
Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry.利用激光流式细胞术分析柔红霉素在人白血病细胞中的摄取异质性。
Invest New Drugs. 1985;3(3):273-7. doi: 10.1007/BF00179431.
5
High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia.
Cancer Chemother Pharmacol. 1987;20(3):265-6. doi: 10.1007/BF00570500.